scholarly article | Q13442814 |
P50 | author | David W Fardo | Q57014856 |
P2093 | author name string | Kevin P Koster | |
Leon M Tai | |||
Yuriko Katsumata | |||
Felecia M Marottoli | |||
Riya Thomas | |||
P2860 | cites work | Neuroprotective effects of granulocyte colony-stimulating factor and relationship to promotion of angiogenesis after spinal cord injury in rats: laboratory investigation | Q84487140 |
Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma | Q86874224 | ||
Cerebrovascular disease in ageing and Alzheimer's disease | Q26771852 | ||
The impairment of insulin signaling in Alzheimer's disease | Q26863763 | ||
The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype | Q26999358 | ||
Alzheimer's-related peptide amyloid-β plays a conserved role in angiogenesis | Q27300765 | ||
Pathophysiology of the neurovascular unit: disease cause or consequence? | Q27690845 | ||
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium | Q28252389 | ||
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans | Q28567974 | ||
Java Treeview--extensible visualization of microarray data | Q29547226 | ||
Open source clustering software | Q29547702 | ||
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders | Q29615839 | ||
Neurovascular regulation in the normal brain and in Alzheimer's disease | Q29619659 | ||
CCL2 disrupts the adherens junction: implications for neuroinflammation | Q30523821 | ||
Blood-brain barrier impairment in dementia: current and future in vivo assessments | Q30881083 | ||
Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system | Q33303316 | ||
Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development | Q33375711 | ||
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. | Q33717326 | ||
IL-17 contributes to angiogenesis in rheumatoid arthritis | Q33802908 | ||
The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease | Q33841363 | ||
Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease | Q34016371 | ||
APOε4 is associated with enhanced in vivo innate immune responses in human subjects | Q34017080 | ||
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. | Q34170081 | ||
Cerebral microvascular pathology in aging and Alzheimer's disease | Q34224715 | ||
A comparative review of toll-like receptor 4 expression and functionality in different animal species | Q34431296 | ||
Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain | Q34531006 | ||
The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis | Q34533560 | ||
Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease. | Q34614881 | ||
Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study | Q34655640 | ||
Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model | Q34978900 | ||
APOE and Alzheimer disease: a major gene with semi-dominant inheritance | Q35181990 | ||
Comparison of Vascular Perturbations in an Aβ-Injected Animal Model and in AD Brain | Q35240139 | ||
Alzheimer's disease: one disorder, too many genes? | Q35649572 | ||
Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors | Q35661943 | ||
Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway | Q35662397 | ||
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases | Q35768362 | ||
Brain morphology links systemic inflammation to cognitive function in midlife adults | Q35868042 | ||
LPS Induces Occludin Dysregulation in Cerebral Microvascular Endothelial Cells via MAPK Signaling and Augmenting MMP-2 Levels | Q35935524 | ||
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody. | Q35968298 | ||
Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy | Q36114568 | ||
Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4. | Q36224032 | ||
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer | Q36228506 | ||
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease | Q36229619 | ||
Inflammation in hypertension. | Q36398035 | ||
APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. | Q36451896 | ||
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease | Q36491332 | ||
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. | Q36583003 | ||
Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. | Q36593210 | ||
The role of APOE in cerebrovascular dysfunction | Q36813704 | ||
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation | Q36916025 | ||
Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease | Q37078772 | ||
Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice. | Q37374629 | ||
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease | Q37439528 | ||
Vascular risk factor detection and control may prevent Alzheimer's disease | Q37729423 | ||
Vascular pathology in Alzheimer's disease | Q37770516 | ||
Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk | Q38175420 | ||
Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease | Q38407944 | ||
EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease. | Q38733357 | ||
CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells | Q38936040 | ||
Cytokine-induced changes in the gene expression profile of a human cerebral microvascular endothelial cell-line, hCMEC/D3 | Q39094145 | ||
Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction | Q39212709 | ||
Epidermal growth factor prevents oligomeric amyloid-β induced angiogenesis deficits in vitro. | Q39383177 | ||
Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging | Q39591436 | ||
Cerebral amyloid angiopathy. A critical review | Q39762877 | ||
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer | Q39853277 | ||
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk | Q40822179 | ||
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons | Q41678964 | ||
Morphological Changes of Blood Vessels in the Brain with Alzheimer's Disease | Q41845578 | ||
Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy | Q41906680 | ||
CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment | Q42183259 | ||
Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier | Q42259826 | ||
Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease | Q42452339 | ||
Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. | Q42458489 | ||
Cerebrovascular pathology during the progression of experimental Alzheimer's disease | Q42487571 | ||
Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study | Q42925710 | ||
Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways | Q44395025 | ||
The amyloid precursor protein of Alzheimer's disease is released by human platelets. | Q44474791 | ||
Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study | Q44493428 | ||
Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model | Q44743810 | ||
Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. | Q44867828 | ||
Stem cell factor and granulocyte colony-stimulating factor exhibit therapeutic effects in a mouse model of CADASIL. | Q44888581 | ||
Prolonged elevation in hippocampal Aβ and cognitive deficits following repeated endotoxin exposure in the mouse | Q48016283 | ||
Beta amyloid angiogenic activity in vitro and in vivo | Q48255154 | ||
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis. | Q48281414 | ||
Granulocyte Colony-Stimulating Factor Attenuates Blood-Brain Barrier Damage and Improves Cognitive Function in Spontaneously Hypertensive Rats | Q48318674 | ||
Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning | Q48377732 | ||
Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Abeta peptides in mouse models of Alzheimer's disease | Q48460015 | ||
Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status | Q48558639 | ||
Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease | Q48633534 | ||
Systemic administration of lipopolysaccharide and interleukin-1beta have different effects on memory consolidation | Q48789301 | ||
Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. | Q48830733 | ||
Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models | Q48833407 | ||
Peripheral lipopolysaccharide administration impairs two-way active avoidance conditioning in C57BL/6J mice. | Q51991522 | ||
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. | Q53186541 | ||
Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis | Q57691308 | ||
Inflammation and atherosclerosis | Q80015206 | ||
TNF-alpha induced NFκB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells | Q82789631 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 4 | |
P304 | page(s) | 1759091417719201 | |
P577 | publication date | 2017-07-01 | |
P1433 | published in | ASN Neuro | Q20312578 |
P1476 | title | Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction | |
P478 | volume | 9 |
Q64922265 | A Fragment of Apolipoprotein E4 Leads to the Downregulation of a CXorf56 Homologue, a Novel ER-Associated Protein, and Activation of BV2 Microglial Cells. |
Q89841160 | Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How |
Q89841154 | Beyond the CNS: The many peripheral roles of APOE |
Q93186219 | Comparison of Single Phase and Biphasic Extraction Protocols for Lipidomic Studies Using Human Plasma |
Q64990193 | Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration. |
Q41471296 | Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer's Disease Brain |
Q89965814 | Murine Gut Microbiome Association With APOE Alleles |
Q64998505 | Non-coding RNA influences in dementia. |
Q50072580 | Noncoding RNAs in Alzheimer's disease |
Q47642585 | Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease. |
Q91777928 | The transcript expression levels of HNRNPM, HNRNPA0 and AKAP17A splicing factors may be predictively associated with ageing phenotypes in human peripheral blood |
Q52314490 | Viral induced oxidative and inflammatory response in Alzheimer's disease pathogenesis with identification of potential drug candidates: A systematic review using systems biology approach. |
Q57821144 | Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions |